Sign in

CIK 0001583648 · Non-accelerated filer<br>Smaller reporting company

PALVELLA THERAPEUTICS, INC.

Sign in to watch
Ticker
PVLA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
operating
EIN
300784346
Phone
(484) 253-1461
Business address
353 W. LANCASTER AVENUE, SUITE 200, WAYNE, PA, 19087
Former names
PIERIS PHARMACEUTICALS, INC., Marika Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$11,725,861
in 7 filings, $11.7M under 10b5-1 plans

Net −$11,725,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. JENKINS GEORGE M −$7.7M Director sold 29% of stake
  2. Martini Jeffrey S −$2.1M Chief Scientific Officer sold 100% of stake
  3. Goin Kathleen −$1.8M Chief Operating Officer sold 100% of stake
  4. KIRITSY CHRISTOPHER P −$49K Director sold 56% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-02-05 Martini Jeffrey S Chief Scientific Officer Grant or award · Incentive Stock Option (right to buy) +5,373 5,373
2025-02-05 Martini Jeffrey S Chief Scientific Officer Grant or award · Non-Qualified Stock Option (right to buy) +123,559 123,559
2025-02-05 Goin Kathleen Chief Operating Officer Grant or award · Incentive Stock Option (right to buy) +5,373 5,373
2025-02-05 Goin Kathleen Chief Operating Officer Grant or award · Non-Qualified Stock Option (right to buy) +123,559 123,559
2025-02-05 Korenberg Matthew E CFO and Treasurer Grant or award · Incentive Stock Option (right to buy) +5,373 5,373
2025-02-05 Korenberg Matthew E CFO and Treasurer Grant or award · Non-Qualified Stock Option (right to buy) +123,559 123,559
2025-02-05 PALVELLA THERAPEUTICS, INC. Chief Scientific Officer Grant or award · Incentive Stock Option (right to buy) +5,373 5,373
2025-02-05 PALVELLA THERAPEUTICS, INC. Chief Scientific Officer Grant or award · Non-Qualified Stock Option (right to buy) +123,559 123,559
2025-02-05 PALVELLA THERAPEUTICS, INC. CFO and Treasurer Grant or award · Incentive Stock Option (right to buy) +5,373 5,373
2025-02-05 PALVELLA THERAPEUTICS, INC. CFO and Treasurer Grant or award · Non-Qualified Stock Option (right to buy) +123,559 123,559
2025-02-05 PALVELLA THERAPEUTICS, INC. President and CEO Grant or award · Non-Qualified Stock Option (right to buy) +243,831 243,831
2025-02-05 PALVELLA THERAPEUTICS, INC. Chief Operating Officer Grant or award · Incentive Stock Option (right to buy) +5,373 5,373
2025-02-05 PALVELLA THERAPEUTICS, INC. Chief Operating Officer Grant or award · Non-Qualified Stock Option (right to buy) +123,559 123,559
2024-12-18 JENKINS GEORGE M Director Purchase +4,000 $12.93 $52K 180,671
2024-12-13 HERON ELAINE J Director Grant or award · Stock Option (right to buy) +24,700 24,700
2024-12-13 Wessel Tadd S. Director Grant or award · Stock Option (right to buy) +24,700 24,700
2024-12-13 Davis Todd C Director Grant or award · Stock Option (right to buy) +24,700 24,700
2024-12-13 Martini Jeffrey S Chief Scientific Officer Grant or award · Stock Option (right to buy) +126,416 126,416
2024-12-13 Goin Kathleen Chief Operating Officer Grant or award · Stock Option (right to buy) +27,843 27,843
2024-12-13 Korenberg Matthew E CFO, Treasurer Grant or award · Stock Option (right to buy) +167,100 167,100

Page 9 of 12 · 232 trades